Stock data
Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. (TVRD) reported net income of -US$18.21M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$26.75M | -US$18.21M | — |
| 2024 | US$7.14M | — | -US$28.11M | -US$29.40M | — |
| 2023 | US$20.97M | — | -US$121.50M | -US$118.51M | — |
| 2022 | US$41.87M | — | -US$87.53M | -US$85.47M | — |
| 2021 | US$23.03M | — | -US$89.08M | -US$88.44M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$6.46M | — |
| 2026-03-31 | — | -US$6.80M | — |
| 2025-12-31 | — | -US$7.28M | — |
| 2025-09-30 | — | -US$5.53M | — |
| 2025-06-30 | — | US$4.17M | — |
| 2025-03-31 | US$2.57M | -US$9.58M | — |
| 2024-12-31 | US$1.46M | -US$12.71M | — |
| 2024-09-30 | US$2.56M | -US$5.51M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.